Medscape Conference Coverage, based on selected sessions at the:
American Society of Clinical Oncology 35th Annual Meeting
May 15, 1999 - May 18, 2000, Atlanta, Georgia
This activity is not sanctioned by, nor a part of, the American Society of Clinical Oncology 35th Annual Meeting. Click here for more information on this Medscape program.
Day 1 - Saturday, May 15 CME Chemotherapy, Chemoradiation for Advanced Lung Cancer Thomas J. Lynch MD Taxanes, Herceptin, and Weekly Therapy: New Options in Metastatic Breast Cancer George W. Sledge, Jr MD Alternatives to 5-FU and Other, Newer Approaches to Breast Cancer Joseph A. Sparano MD more...
Day 2 - Sunday, May 16 CME Lung Cancer: Breathing New Life Into Locally Advanced NSCLC and Stage IV Disease Corey J. Langer MD Locally Advanced NSCLC: Concurrent vs Sequential Therapy Corey J. Langer MD Optimizing Local Treatment of Early-Stage Prostate Cancer: Determining Which Patients Benefit From the Addition of Neoadjuvant Androgen Deprivation Diane M. Savarese MD more...
Day 3 - Monday, May 17 CME Adjuvant Therapy in Breast Cancer: What's the Best Regimen? Edith A. Perez MD High-Dose Therapy in Breast Cancer: New Studies Stoke an Ongoing Debate Patrick J. Stiff MD SERMs and Breast Cancer Melody A. Cobleigh MD more...
Day 4 - Tuesday, May 18 CME Breast Cancer Prevention: Raloxifene's Role Still Being Studied Melody A. Cobleigh MD BRCA-1/2 Mutations: Implications for Prognosis, Treatment Outcome, and Prevention Andrew Seidman MD What's New in Managing Hot Flashes in Women with Breast Cancer? Edith A. Perez MD more...
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, Inc., and do not represent a publication of the American Society of Clinical Oncology. These materials and the related activity are not sanctioned by the American Society of Clinical Oncology or the sponsors of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
Chemotherapy, Chemoradiation for Advanced Lung Cancer